Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.

Goldspiel, B R; Kohler, D R

Goldspiel, B R; Kohler, D R.

Obstet Gynecol ; 84(3): 483-4, 1994 Sep.

Article in En | MEDLINE | ID: mdl-8058256

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Metoclopramide/therapeutic use; Ondansetron/therapeutic use; Vomiting/chemically induced; Vomiting/prevention & control; Carboplatin/administration & dosage; Cisplatin/administration & dosage; Female; Humans; Research Design

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Antineoplastic Combined Chemotherapy Protocols / Ondansetron / Metoclopramide Limits: Female / Humans Language: En Journal: Obstet Gynecol Year: 1994 Type: Article

Search on Google

XML

PubMed Links